The mouse lymphoma assay (MLA), using the thymidine kinase (Tk) gene of the L5178Y/Tk þ/À -3.7.2C mouse lymphoma cell line as a reporter gene of mutation, is preferred by a number of international regulatory agencies, including the United States Food and Drug Administration and the United States Environmental Protection Agency, as the in vitro mammalian mutation assay in the genetic toxicology screening battery. The decision to prefer the MLA was based on previous research demonstrating that the assay detects most of the mutational events known to be associated with the etiology of cancer and other human diseases, including point mutations and a number of different types of chromosomal mutations (Applegate et al., Blazak et al., 1989; Chen et al., 2002; Clive et al., 1990; Honma et al., 2001; Hozier et al., 1981 Hozier et al., , 1992 Liechty et al., 1998; Moore et al., 1985; Zhang et al., 1996) .
It is important to determine the various mutation types that can be detected by this assay, so that MLA data can be properly interpreted. Since the development of this assay, quite a number of studies have been conducted to understand the types of mutations that can be detected by the MLA. Several cytogenetic studies have been conducted to analyze Tk mutants induced by various mutagens (Blazak et al., 1986 (Blazak et al., , 1989 Hozier et al., 1981; Moore et al., 1985; Zhang et al., 1996) . It is clear that many small colony (SC) mutants have recognizable chromosome rearrangements involving chromosome 11, which contains the Tk gene. The Tk À and Tk þ chromosomes can be distinguished by a centromeric heteromorphism: the Tk þ chromosome has a bigger centromere (Hozier et al., 1982; Sawyer et al., 1985) . This finding greatly helps the cytogenetic characterization of chromosome aberrations in Tk mutants. However, without the help of molecular genetics, small chromosome changes cannot be detected using cytogenetic methods alone; mitotic recombination cannot be identified because the karyotype of the mutant would be normal. Applegate et al. (1990) identified a Nco I restriction fragment length polymorphism that distinguishes the Tk þ and Tk À alleles. Several studies using Southern blot analysis to determine the status of the Tk þ allele were subsequently conducted Clive et al., 1990) . The presence of the Tk þ allele suggests an intragenic mutation, while the loss of the Tk þ allele indicates a chromosome mutation. Most large colony (LC) mutants induced by point mutagens, such as ethyl methanesulfonate, retain the Tk þ allele; while most SC mutants induced by clastogens, such as bleomycin, lose the Tk þ allele. An allele-specific PCR technique was developed to identify the presence or absence of the Tk þ allele. Furthermore, based on microsatellite polymorphisms, the loss of heterozygosity (LOH) pattern of the entire chromosome 11 can be investigated (Liechty et al., 1994 (Liechty et al., , 1996 (Liechty et al., , 1998 . This laborsaving approach allows many mutants to be analyzed; however, without the detection of Tk gene copy number (CN), one cannot distinguish between a deletion and a recombination event. Southern blot analysis can be used to detect Tk gene CN , but it is resource intensive, requires a relatively large amount of DNA, and the measurement is not precise (Joseph et al., 1993) . Therefore, we developed a realtime PCR method to detect the CN of the Tk gene (Wang et al., 2007) . By combining LOH analysis of chromosome 11 and cytogenetic analysis, we were able to distinguish between deletion and recombination events.
Another important issue for the MLA is whether the assay can detect aneuploidy. Aneuploidy plays a significant role in many adverse human health conditions, including spontaneous abortions, birth defects, and cancer (Aardema et al., 1998; Duesberg et al., 1999; Oshimura and Barrett, 1986; Sen, 2000) . Aneugens can interact with the spindle apparatus or impair its function, thereby inducing aneuploidy due to nondisjunction mechanisms. Several aneugens are carcinogens (Cimino et al., 1986; Oshimura and Barrett, 1986) . Although the MLA has been shown to detect aneugens, its ability to adequately detect aneuploidy is unclear. Applegate et al. (1990) reported that at least some Tk mutants show aneuploidy. Honma et al. (2001) evaluated two aneugens, colchicine, and vinblastine, using the MLA. The two chemicals did not induce a significant mutant frequency (MF) increase after the regular 3-h treatment. Although they did show positive responses after the long-term (24 h) treatment, the increase of MF was not high. Therefore, many of the mutants that were isolated and analyzed from the chemical-treated cultures would be spontaneous rather than induced mutants.
Overall, the specific types of chromosomal mutations that are detected by the MLA need further clarification. In this study, Tk mutants from cultures treated with different chemicals, including two clastogens and an aneugen (3#-azido-3#-deoxythymidine [AZT], mitomycin C and taxol), were used. A combined strategy of both molecular genetic and cytogenetic methods was used to analyze the mutants. LOH analysis of chromosome 11 was conducted first, and then the Tk mutants showing LOH involving a large portion of chromosome 11 were selected for further cytogenetic analysis and Tk CN detection. It should be noted that it was not our intent to provide a complete analysis of the types of mutational events induced by these three chemicals; rather, we used these chemicals to give us mutants for our analysis that would be expected to include deletions, mitotic recombination, and aneuploidy.
MATERIALS AND METHODS
Cell culture. The L5178Y/Tk þ/À -3.7.2C mouse lymphoma cells were cultured in suspension using Fischer#s medium for leukemic cells of mice (Quality Biologicals, Gaithersburg, MD) supplemented with 10% heatinactivated horse serum, 200 lg/ml sodium pyruvate, 100 unit/ml penicillin, 100 lg/ml streptomycin, and 0.05% (vol/vol) pluronic F68 (Invitrogen, Carlsbad, CA) . The cultures were incubated at 37°C in an atmosphere of 5% CO 2 and saturated humidity and maintained in logarithmic growth.
Tk mutant induction. Tk mutants isolated from AZT-treated and taxoltreated cultures were from previous studies using the microwell version of the assay Wang et al., 2007) . For the induction of Tk mutants using mitomycin C (obtained from Sigma, St Louis, MO), the protocol for the microwell version of the mouse lymphoma assay described by Chen and Moore (2004) was followed. Briefly, cells were centrifuged and resuspended at a concentration of 0.2 3 10 6 cells/ml in 50 ml of medium in 75-cm 2 polystyrene flasks. Mitomycin C dissolved in dimethyl sulfoxide (DMSO) was added from a stock solution to the cell cultures. Additional DMSO was added to give a final volume of 100 ll. The flasks were incubated for 4 h, and then the cells were centrifuged, washed twice, and resuspended in fresh medium. The cells were transferred to new 75-cm 2 flasks and cultured for 2 days for mutant expression with cell counts and cell density adjustment made after 1 day. Then the cells were cloned in 96-well plates in medium containing 3 lg/ml trifluorothymidine (TFT) for selection and medium without TFT for the measurement of cloning efficiency. After 12 days, the 96-well plates were evaluated by eye using a Quebec dark field colony counter to determine the presence or absence of colonies in each well and to enumerate the number of small and LC mutants. Total MF, SC MF, and LC MF were determined, and the relative total growth values that measures cytotoxicity were calculated according to the published protocol (Chen and Moore, 2004) . Mutant colonies were randomly selected and isolated from the cultures treated with the highest test dose of AZT (1 mg/ml), mitomycin C (0.4 lg/ml), or taxol (1 lg/ml), respectively.
DNA extraction. The isolated mutant colonies were cultured in fresh medium for several days to obtain sufficient cells for subsequent analysis. Genomic DNA was extracted from 3 3 10 6 cells of each Tk mutant clone using the Qiagen DNeasy tissue kit (Valencia, CA) and stored at À 20°C.
Tk gene LOH analysis. Tk gene LOH analysis was conducted using the allele-specific PCR described by Liechty et al. (1996) , with some modifications (Wang et al., 2007) . Basically, the microsatellite locus D11Agl2 that resides in the Tk gene was amplified using a touchdown PCR method. The PCR was performed in 96-well plates using a PCR System 9700 (Applied Biosystems, Foster City, CA). The reaction products were separated by 2% agarose gel electrophoresis, stained with 1 lg/ml ethidium bromide, and visualized with a UV light box.
Chromosome 11 LOH analysis. In addition to microsatellite marker D11Agl2, eight other microsatellite loci on mouse chromosome 11 (D11Mit 42, 59, 36, 29, 22, 20, 19 , and 74) were used (Wang et al., 2007) . The nine microsatellite loci are almost evenly distributed along the length of the chromosome (with locations at 78.0, 72.0, 58.5, 47.6, 40.0, 25.0, 20.0, 13.0, and 0.0cM, respectively) . LOH analysis was performed at each microsatellite locus using allele-specific PCR as previously described (Wang et al., 2007) . The PCR products were separated and visualized as above.
Tk gene dosage analysis. For those mutants showing LOH involving a large portion of chromosome 11 (at least including microsatellite markers D11Agl2 and D11Mit 42), Tk gene CN was evaluated using the real-time PCR 2
ÀDDCt method described previously (Wang et al., 2007) . Briefly, a fragment of the Tk gene and a fragment of an unrelated gene (H-2K) on chromosome MLA DETECTS RECOMBINATION, DELETION, AND ANEUPLOIDY 97 17 were amplified simultaneously. The H-2K gene fragment was used as an endogenous reference for PCR relative quantitation. According to the criteria set by Honma et al. (2001) , the CN of Tk mutants was classified as <1.2, 1.2-1.8, and >1.8, which sets the ranges for the hemizygous, mosaic, and homozygous states of the Tk gene, respectively.
G-banding analysis. For the mutants showing LOH involving a large portion of chromosome 11 (at least including microsatellite markers D11Agl2 and D11Mit 42), G-banding analysis was performed to examine the alteration of chromosome 11. The protocol established by Sawyer et al. (1985) was followed with some revision. Briefly, a 12-ml cell culture (approximately 8-10 3 10 6 cells) was centrifuged at 200 3 g for 10 min. The supernatant was discarded, and the cell pellet was resuspended with gentle agitation in a hypotonic solution (10 ml 75mM KCl). Then 120 ll of 10 lg/ml colchicine (Sigma) was added. The cell suspension was then incubated at 37°C for 20 min. Five drops of fixative (5:2, methanol:acetic acid) were added at the end of incubation with gentle agitation to avoid cell clumping. Then the cells were centrifuged, and the supernatant was discarded leaving approximately 0.5 ml of solution over the pellet. The pellet was then gently agitated, and 10 ml of fixative was added. After gentle mixing, the cell suspension was incubated at room temperature for 20 min. The cell suspension was centrifuged, and the fixative was changed twice to eliminate cell debris and to ensure good spreading and staining of chromosomes. The cell pellet was resuspended in about 1 ml fixative to make the slides. For karyotypic analysis, cells were dropped onto precleaned glass slides (soaked in 95% ethanol overnight) and air dried. Trypsin treatment before Giemsa staining was used to sharpen bands and increase contrast. At least 10 cells were examined per clone.
Chromosome painting analysis. Chromosome 11 painting analysis was performed as described by Zhang et al. (1996) with some modification. Briefly, colchicine was added to a 12-ml cell culture (approximately 8-10 3 10 6 cells) at a final concentration of 0.5 lg/ml. Cells were incubated for 1 h at 37°C in an atmosphere of 5% CO 2 and saturated humidity. Then the cell culture was centrifuged at 200 3 g for 10 min and resuspended in hypotonic solution (75mM KCl), followed by incubation in a water bath at 37°C for 20 min. After that, five drops of fixative (3:1, methanol:acetic acid) were added with gentle agitation. The rest of the cell fixation was accomplished using the procedure described in the G-banding analysis section above.
A whole-chromosome painting probe specific for mouse chromosome 11 labeled with biotin was purchased from Cambio (Cambridge, UK). The chromosome painting procedure described in the manufacturer's instructions was followed. Briefly, chromosomal DNA on slides was denatured with 23 sodium chloride-sodium citrate buffer (SSC)-70% formamide solution (13 SSC is 0.15M NaCl þ 0.015M sodium citrate) at 70°C for 2 min followed by dehydration through an ethanol series (70%, 85%, and 100%). Probes were added to the metaphase preparations. After overnight hybridization at 37°C, the slides were washed three times with 23 SSC-50% formamide solution and three times with 23 SSC at 45°C. The slides were then incubated with fluorescent avidin-DCS (Vector Laboratories, Burlingame, CA) solution at 37°C for 30 min and washed with 23 SSC containing 0.1% Tween 20. The slides were then incubated with biotinylated goat anti-avidin DCS (Vector Laboratories) at 37°C for 30 min followed by a second fluorescent avidin-DCS treatment. The slides were washed, counterstained with propidium iodide solution, and mounted. At least 10 metaphases from each slide were examined with fluorescence microscopy.
RESULTS
The Tk MFs for the AZT-, mitomycin C-, and taxol-treated cultures used for mutant analysis are shown in Table 1 . The complete MF data for AZT can be found in Wang et al. (2007) , for taxol in Moore et al., (2005) , and for mitomycin C in Figure 1 . At the highest dose tested, all three chemicals induced high Tk MFs (4.8-, 16.6-, and 7.3-fold over the concurrent negative control for AZT, mitomycin C, and taxol, respectively). This indicated that most of the analyzed Tk mutants were chemicalinduced mutants rather than spontaneous background mutants.
For our detailed analysis to determine if mutants can result from deletion, mitotic recombination, and aneuploidy, we needed mutants with large chromosomal alterations. Therefore, a number of mutants were first screened using nine microsatellite markers spanning chromosome 11. Mutants showing partial chromosome 11 LOH including at least microsatellite markers Agl2 and Mit42 were selected for further analysis using G-banding. In addition, Tk gene CN of these mutants was evaluated. Chromosome painting analysis was performed for some of the mutants showing LOH at every chromosome 11 microsatellite marker.
Fifteen mutants from the 1-mg/ml AZT-treated culture (Wang et al., 2007) showing LOH including at least microsatellite markers Agl2 and Mit42 were analyzed using G-banding analysis. Nineteen mutants from the 0.4-lg/ml mitomycin C-treated culture were analyzed using chromosome 11 LOH analysis; then four mutants showing partial chromosome 11 LOH were analyzed using Tk gene dosage analysis and G-banding analysis, and two mutants showing LOH at every microsatellite marker on chromosome 11 were analyzed using chromosome painting analysis. Twenty mutants from the 1-lg/ml taxol-treated culture were isolated for chromosome 11 LOH analysis, and seven mutants showing LOH at every microsatellite marker on chromosome 11 were analyzed using chromosome painting analysis. The number of mutants that were analyzed using the combined strategy is summarized in Table 2 .
The results of the G-banding analysis can be classified as normal chromosome 11, visible deletion, or complex chromosome alterations. The number of chromosome 11 revealed by the chromosome painting analysis can be classified as one (indicating chromosome loss), two (indicating chromosome duplication after loss), or more than two (including either aneuploidy or polyploidy). The numbers of metaphase spreads showing different numbers of chromosome 11 as revealed by chromosome painting are shown in Table 3 . The combined results of the chromosome 11 LOH analysis, Tk CN detection, and G-banding/chromosome painting analysis are shown in Table 4 .
In total, 28 mutants showing partial or complete chromosome 11 LOH were analyzed using this combined strategy. Among them, nine mutants (A1B4, A1B5, A2D4, A3C2, A5B3, A6A2, ML4, ML10, and MS6) retained a normal karyotype, while at least three microsatellite markers showed LOH. With a Tk CN of 2, the mutation type of these mutants can be identified as recombination. A representative metaphase cell is shown in Figure 2 . Five mutants (A1C6, A3A4, A5C2, A5D6, and A6C2) were identified to be deletions. They all have partial chromosome 11 LOH patterns, one copy of the Tk gene, and chromosome 11 showing visible deletions or deletions combined with translocation (representative metaphase cell shown in Fig. 2 ). Five mutants (A5C6, A5D2, A7B5, A7C1, and MS8) showed complex chromosome alterations. They all have partial chromosome 11 LOH patterns, with more than one copy of the Tk gene. G-banding analysis showed that the Tk À chromosome appears to be normal, while the Tk þ chromosome is abnormally long (Fig. 3) . It is speculated that this complex alteration was the result of multiple events: deletion, duplication (aneuploidy), and translocation. First, the Tk þ chromosome was partially deleted, which resulted in the LOH pattern; then the Tk À chromosome was duplicated and translocations occurred. The duplicated Tk À chromosome was translocated directly to the damaged Tk þ chromosome or other chromosomes. Mutants A5D2 and MS8 have Tk CNs between 1 and 2, indicating that they are mosaic mutants. They may be a mixture of cells with duplicated Tk À chromosome after the partial deletion of the Tk þ chromosome or the Tk À chromosome was not duplicated. For those mutants that showed complete LOH of chromosome 11 (ML7, MS3, TL2, TL4, TL8, TS2, TS4, TS6, and TS7), chromosome painting analysis indicated that they were all mosaic mutants, and overall the major mechanism appears to be the Tk À chromosome duplication after the loss of the Tk þ chromosome. Representative photos for chromosome loss and chromosome duplication after loss are shown in Figure 4 .
DISCUSSION
A complete evaluation of genetic toxicology data includes an analysis of the mode of action by which the test chemical induced mutation (Dearfield and Moore, 2005) . Because there are a number of genotoxicity tests and different tests detect different types of genotoxic damage, they may give a mixture of both positive and negative results. Therefore, it is important to identify the types of mutations detected by the different assays in order to evaluate the data properly.
As mentioned before, it has been established that the MLA can detect both point mutations and chromosomal mutations The first letter of the mutant name indicates the chemical exposure (M, mitomycin C; T, taxol); the second letter indicates colony size of the mutant (L, large; S, small). All the mutants showed LOH at every microsatellite marker on chromosome 11. Ten metaphase spreads were counted for each Tk mutant. Chen et al., 2002; Honma et al., 2001; Hozier et al., 1981; Liechty et al., 1998; Moore et al., 1985) . A large experimental trial including 45 labs (Honma et al., 1999) suggested that the MLA and the in vitro chromosome aberration test were basically ''equivalent'' as to their ability to give positive responses for clastogens. It is important to recognize that the MLA detects small-scale alterations that are too small to be detected by cytogenetic assays. In addition, the MLA detects recombination, which may lead to recessive mutations and plays an important role in the deactivation of The first letter of the mutant name indicates the chemical exposure. A, AZT; M, mitomycin C; T, taxol. For mutants from AZT-treated culture, LOH analysis and Tk gene CN detection was done in a previous study (Wang et al., 2007) . D11Agl2, D11Mit 42, 59, 36, 29, 22, 20, 19 , and 74 are nine microsatellite markers that are almost evenly distributed along the length of chromosome 11. The Tk gene CN analysis was performed for mutants showing microsatellite LOH for at least markers Agl2 and Mit 42 but also retaining microsatellite heterozygosity for at least marker Mit 74 (partial LOH of chromosome 11).
e G-banding analysis was performed for the mutants showing LOH at least at microsatellite markers Agl2 and Mit 42 but also retaining heterozygosity at least at microsatellite marker Mit 74 (partial LOH of chromosome 11). Chromosome painting analysis was performed for the mutants showing LOH at every microsatellite marker on chromosome 11 (complete LOH of chromosome 11). tumor suppressor genes during tumorigenesis. Recombination events are not detected by cytogenetic assays. Liechty et al. (1998) speculated that the MLA is able to detect recombination because of the autosomal location and the heterozygous status of the Tk gene. There is also evidence that the MLA can detect aneuploidy. It is especially important for regulatory purposes to collect more evidence demonstrating that the MLA is capable of detecting aneuploidy and recombination.
For our analysis, we needed mutants that were the result of deletion, mitotic recombination, or aneuploidy. For this purpose, we used three chemicals (AZT, mitomycin C, and taxol) to induce Tk mutants. AZT is a thymidine analogue that is clastogenic (Wang et al., 2007) . Mitomycin C is a potent clastogen, and it induces mutations in the Tk gene (Davies et al., 1993; Dobrovolsky et al., 2002) . Taxol can impair cell spindles and induce aneuploidy (Ikui et al., 2005; Mailhes et al., 1999; Schiff and Horwitz, 1980) . As mentioned earlier, Honma et al. (2001) performed an analysis of Tk mutants using two aneugens, colchicine and vinblastine. The increase in MF was not very high, even after a 24-h treatment (3.6-and 2.3-fold over the control, for colchicine and vinblastine, respectively), so the mutants isolated and analyzed from these chemically treated cultures would include a large number of spontaneous mutants. In the present study, the MFs were much higher (4.8-to 16.6-fold over the control), indicating that many to most of the analyzed mutants were induced by the test chemicals.
Early cytogenetic studies of MLA Tk mutants showed that many SC mutants have recognizable chromosome aberrations involving the chromosome 11 that carries the Tk þ allele. At that time, the chromosome aberrations identified in Tk mutants were primarily translocations (Blazak et al., 1986; Hozier et al., 1981; Moore et al., 1985) . Later, Southern blot analysis and an allele-specific PCR technique were used to determine the status of the Tk allele Liechty et al., 1994 Liechty et al., , 1996 . Most of the SC mutants (both spontaneous and from treated cultures) and a large fraction of LC mutants (depending upon the mutagen) showed the loss of the Tk þ allele, which indicates that the MLA is able to detect LOH, the most common mutational mechanism in human cancer. Liechty et al. (1998) analyzed a large number of spontaneous Tk mutants using LOH analysis as well as chromosome painting. Their analysis provided evidence to support the hypothesis that the MLA detects recombination. However, the mutants they analyzed were all spontaneous 
FIG. 4.
Chromosome painting analysis of mouse lymphoma Tk mutants TL8 and TL2 that were isolated from a culture treated with 1 lg/ml taxol. The chromosome 11 probe is labeled with red fluorescence. The top photo for mutant TL8 shows only one chromosome 11 (chromosome loss). The bottom photo for mutant TL2 shows two chromosome 11 (chromosome duplication after loss).
102 WANG ET AL. that the ''longer'' chromosome 11 was actually formed by two (or two parts of) chromosome 11 in an unbalanced translocation, while the ''shorter'' chromosome 11 was actually a normal Tk À chromosome (Fig. 5) . Therefore, in this study we used a combination of all the different analysis methods to identify the mutation types. Interestingly, five mutants (four from the AZT treatment and one from mitomycin C) were found to have alterations similar to mutant 950: deletion with aneuploidy. The proportion of this specific aberration in the mutants we analyzed is very high: 5 of the 19 analyzed were partial chromosome 11 LOH mutants. The underlying mechanism for this event is unclear. We speculate that the Tk À chromosome duplication is some type of compensation for the deletion of the Tk þ chromosome, resulting in partial trisomy (aneuploidy). This unique aberration may be related to the clastogenicity of the chemical: AZT, mitomycin C, and bleomycin are all clastogens.
Although chromosome loss is the primary mutation mechanism whereby aneugens induce Tk À -deficient mutants, few cells were found to be monosomic for chromosome 11 in this study. We analyzed nine mutants showing complete chromosome 11 LOH. The majority were mosaic with most having chromosome duplication after loss. This probably occurs because duplication of the Tk À chromosome is a repair/ compensation mechanism after the loss of the Tk þ chromosome. Cells containing two Tk À chromosomes would be expected to have a growth advantage over cells containing only one Tk À chromosome, thereby becoming the predominant cell type in the culture (Honma et al., 2001) .
The results clearly demonstrate that MLA Tk mutants can result from recombination, deletion, and aneuploidy. The ability to detect recombination is a particular advantage of the MLA. Recombination is an important pathway for repairing DNA double-strand breaks, and it is essential for cellular survival in mammals (Helleday, 2003) . It cannot be detected by assays using hemizygous reporter genes, such as Hprt. The ability to detect large deletions is another advantage of the MLA. This may be due to the Trp53 status of the L5178Y/Tk þ/ À mouse lymphoma cell line. In this cell line, both alleles of the Trp53 gene have point mutations, one of which likely results in no protein production (the point mutation produces a stop codon) and the other results in the production of a mutant Trp53 (Clark et al., 1998; Storer et al., 1997) . Large-scale damage may be incompatible with the survival of Trp53-sufficient cells; these cells will undergo apoptosis under the surveillance of Trp53 (Honma et al., 2000) . The Trp53 status may also play a critical role in the ability of the MLA to detect aneuploidy (Honma et al., 2001) . In mammalian cells, Trp53 is involved in the maintenance of diploidy by participating in a mitotic checkpoint and the regulation of centrosome duplication (Cross et al., 1995; Honma et al., 2001; Tarapore and Fukasawa, 2000) .
It should be emphasized that while this analysis indicates that the MLA can detect newly induced deletions, mitotic recombination, and aneuploidy, it does not provide insight into the relative proportion of the various types of mutational events or the efficiency with which these events are detected. While we have combined several powerful techniques to elucidate the mutations, all these techniques are very ''blunt'' tools. The nine LOH markers were distributed across chromosome 11, but from the perspective of potentially mutable sites, only a tiny fraction of the chromosome could be evaluated. Furthermore, our strategy of combining the G-banding analysis with the LOH analysis to distinguish between deletion and mitotic recombination required that the breakpoints be located so that at least approximately 25% MLA DETECTS RECOMBINATION, DELETION, AND ANEUPLOIDY of the chromosome would be deleted (and readily visible by banded karyotype) if the mutant were a deletion rather than resulting from mitotic recombination. To understand the mechanism for the induction of every mutant, and ultimately to fully understand the fundamental differences between the small and LC Tk mutants, the analysis must be conducted in a way that can interrogate a much larger portion of chromosome 11. We are currently initiating a research project to utilize comparative genomic hybridization microarray technology in combination with our current tools.
Our present study clearly demonstrates that the MLA can, in fact, detect deletion, recombination, and aneuploidy and provides new evidence for the utility of the MLA in a mechanistically based genotoxicity hazard identification battery. Depending upon the question that is being addressed and the importance of understanding the mutations induced by a particular chemical, our strategy of combining cytogenetic and molecular analysis of mutants can be used to provide more than a simple mutagenic/nonmutagenic hazard assessment. 
